Jeremy Jones (@jcj84jeremy) 's Twitter Profile
Jeremy Jones

@jcj84jeremy

GI Medical Oncologist at Mayo Clinic Jacksonville.

ID: 2207772032

linkhttp://www.mayoclinic.org calendar_today21-11-2013 20:19:50

1,1K Tweet

1,1K Takipçi

594 Takip Edilen

Prof FTO 🇳🇬🇺🇸 (@drodedina) 's Twitter Profile Photo

🎉 The countdown to #AACR25 continues. As one of the Program Committee Co-chairs for the AACR Annual Meeting 2025, I look forward to welcoming you to Chicago! 🙌🏾 Let’s connect, collaborate, and advance the future of cancer research—together. 💡🔬 #AACR2025 #CancerResearch 👇🏽

🎉 The countdown to #AACR25 continues. As one of the Program Committee Co-chairs for the <a href="/AACR/">AACR</a> Annual Meeting 2025, I look forward to welcoming you to Chicago! 🙌🏾 Let’s connect, collaborate, and advance the future of cancer research—together. 💡🔬
#AACR2025 #CancerResearch 
👇🏽
Rami Manochakian MD, FASCO Cancer Education (@rmanochakian) 's Twitter Profile Photo

📣🚨Checkout this just published great article ASCO #Connection on a very important topic for #Oncologists & #Trainees: ✅“#Burnout & #Resilience” ⭐️By two amazing fellows & a great faculty in our program, Dina Elantably, MD, MS, #TanmayiPai, @drjasonstarr 👇🏻 connection.asco.org/do/burnout-res…

📣🚨Checkout this just published great article <a href="/ASCO/">ASCO</a> #Connection on a very important topic for #Oncologists &amp; #Trainees:
 
✅“#Burnout &amp; #Resilience”

⭐️By two amazing fellows &amp; a great faculty in our program, <a href="/DinaElantably/">Dina Elantably, MD, MS</a>, #TanmayiPai, @drjasonstarr

👇🏻
connection.asco.org/do/burnout-res…
Dana-Farber’s Breast Oncology Center (@dfci_breastonc) 's Twitter Profile Photo

Check out this recent Annals of Oncology #ctDNA review and meta-analysis👉Circulating tumor DNA clearance as a predictive biomarker of pathologic complete response in patients with solid tumors treated with neoadjuvant immune checkpoint inhibitors. 👉pubmed.ncbi.nlm.nih.gov/40187491/

Check out this recent <a href="/Annals_Oncology/">Annals of Oncology</a> #ctDNA review and meta-analysis👉Circulating tumor DNA clearance as a predictive biomarker of pathologic complete response in patients with solid tumors treated with neoadjuvant immune checkpoint inhibitors. 
👉pubmed.ncbi.nlm.nih.gov/40187491/
Horizon CME (@horizoncme) 's Twitter Profile Photo

📣We're honored to have Dr. Hani Babiker (of Mayo Clinic ) as our course director of STOP Cancer 2025! 🚨Don't miss us for the second annual "STOP Cancer" conference September 25 - 27 in Las Vegas. This conference will highlight the latest in early phase research and

📣We're honored to have Dr. Hani Babiker (of <a href="/MayoClinic/">Mayo Clinic</a> ) as our course director of STOP Cancer 2025!

🚨Don't miss us for the second annual "STOP Cancer" conference September 25 - 27 in Las Vegas. This conference will highlight the latest in early phase research and
Rami Manochakian MD, FASCO Cancer Education (@rmanochakian) 's Twitter Profile Photo

📣It is a true pleasure to host Professor Amer Zeidan MBBS,MHS ‏عامر زيدان A great leader in #HematologicMalignancies & a wonderful colleague from Yale University, giving an outstanding talk at the Mayo Clinic FL Mayo Clinic Comprehensive Cancer Center #GrandRounds on a very important topic: #MyeloDysplasticSyndrome #MDS

📣It is a true pleasure to host Professor <a href="/Dr_AmerZeidan/">Amer Zeidan MBBS,MHS ‏عامر زيدان</a> 

A great leader in #HematologicMalignancies &amp; a wonderful colleague from <a href="/Yale/">Yale University</a>, giving an outstanding talk at the <a href="/MayoClinic/">Mayo Clinic</a> FL <a href="/MayoCancerCare/">Mayo Clinic Comprehensive Cancer Center</a> #GrandRounds on a very important topic:

#MyeloDysplasticSyndrome #MDS
Mayo Clinic (@mayoclinic) 's Twitter Profile Photo

A recent Mayo Clinic study revealed how telehealth can be a powerful tool to enhance patient well-being when strategically applied in healthcare delivery. Learn more about the study: mayocl.in/4mqvttL

A recent Mayo Clinic study revealed how telehealth can be a powerful tool to enhance patient well-being when strategically applied in healthcare delivery. 

Learn more about the study: mayocl.in/4mqvttL
Syed A. Ahmad (@syedaahmad5) 's Twitter Profile Photo

Chemoradiotherapy and Local Excision vs Total Mesorectal Excision in T2-T3ab, N0, M0 Rectal Cancer: The TAUTEM Randomized Clinical Trial ⁦JAMA Surgery⁩ jamanetwork.com/journals/jamas…

Nicholas Hornstein (@gimedonc) 's Twitter Profile Photo

#ASCO2025 🚨 BREAKWATER OS data lands—and it must redefine 1L standard of care in BRAF V600E-mutant mCRC. EC + mFOLFOX6 vs SOC (chemo ± bevacizumab): 📊 PFS: 12.8 vs 7.1 mo (HR 0.53, p < 0.0001) 🧬 OS: 30.3 vs 15.1 mo (HR 0.49, p < 0.0001) ✅ Dual primary endpoints met 🛡️

Mayo Clinic Comprehensive Cancer Center (@mayocancercare) 's Twitter Profile Photo

The practice-changing transformation happening via Cancer Care Beyond Walls is driven by Roxana Dronca, M.D.'s compassion and full understanding of the pain families endure because of cancer. Read about its origins and the patients whose lives it's improving. mayomagazine.mayoclinic.org/2025/05/healin…

Mayo Clinic Comprehensive Cancer Center (@mayocancercare) 's Twitter Profile Photo

.Mayo Clinic Hematology-Oncology Fellowship fellow, Dina Elantably, MD, MS, presented an ongoing pilot study evaluating the feasibility & safety of subcutaneous nivolumab delivery at home through the Cancer CARE Beyond Walls program at #ASCO25. The study aims to reduce treatment burden & improve access for patients.

.<a href="/MayoHemeOnc/">Mayo Clinic Hematology-Oncology Fellowship</a> fellow, <a href="/DinaElantably/">Dina Elantably, MD, MS</a>, presented an ongoing pilot study evaluating the feasibility &amp; safety of subcutaneous nivolumab delivery at home through the Cancer CARE Beyond Walls program at #ASCO25. The study aims to reduce treatment burden &amp; improve access for patients.
Mayo Clinic Comprehensive Cancer Center (@mayocancercare) 's Twitter Profile Photo

While still enrolling, preliminary experience suggests the model is feasible and well tolerated and shows promising potential to inform future models of decentralized, patient-centered #CancerCare. #ASCO25 Read the abstract here: meetings.asco.org/abstracts-pres…

Mayo Clinic (@mayoclinic) 's Twitter Profile Photo

Cancer Care Beyond Walls is giving time back to patients and families with at-home treatment that’s just as safe as in-clinic care. mayocl.in/43I7flX

Mayo Clinic (@mayoclinic) 's Twitter Profile Photo

Virtual care can be a great choice for connecting with healthcare. You can save drive time, avoid bad weather and not be in a clinic where you could infect others. ⁠ ⁠ There are typically three main types of virtual care. Learn more: mayocl.in/4mMceLk

Virtual care can be a great choice for connecting with healthcare. You can save drive time, avoid bad weather and not be in a clinic where you could infect others. ⁠
⁠
There are typically three main types of virtual care. Learn more: mayocl.in/4mMceLk
Chang Wook Jeong (@drboss_urology) 's Twitter Profile Photo

Honored to join #PlatforMed as a founding partner of the Mayo Clinic Platform — an innovation conference with a platform approach. Inspiring talks by John Halamka, M.D., M.S., and Gianrico Farrugia , President of Mayo Clinic, and more. #digitalhealth #AIinHealthcare #UroSoMe #MedTwitter Seoul National University Hospital

Honored to join #PlatforMed as a founding partner of the <a href="/MayoPlatform/">Mayo Clinic Platform</a>  — an innovation conference with a platform approach.

Inspiring talks by <a href="/jhalamka/">John Halamka, M.D., M.S.</a>, and <a href="/GFarrugiaMD/">Gianrico Farrugia</a> , President of <a href="/MayoClinic/">Mayo Clinic</a>, and more.

#digitalhealth  #AIinHealthcare
#UroSoMe #MedTwitter  <a href="/snuh_official/">Seoul National University Hospital</a>
Mayo Clinic Comprehensive Cancer Center (@mayocancercare) 's Twitter Profile Photo

A study led by Mayo Clinic Hematology-Oncology Fellowship's Sikander Ailawadhi, M.D., and presented at #ASCO25, suggests isatuximab for relapsed/refractory #MultipleMyeloma via subcutaneous on-body delivery system is as effective as traditional IV infusions. Read the abstract: ascopubs.org/doi/10.1200/JC…

A study led by <a href="/MayoHemeOnc/">Mayo Clinic Hematology-Oncology Fellowship</a>'s Sikander Ailawadhi, M.D., and presented at #ASCO25, suggests isatuximab for relapsed/refractory #MultipleMyeloma via subcutaneous on-body delivery system is as effective as traditional IV infusions. Read the abstract: ascopubs.org/doi/10.1200/JC…
Rami Manochakian MD, FASCO Cancer Education (@rmanochakian) 's Twitter Profile Photo

🔥🚨Hot off the press JUST published ASCO #Connection An article on: “Building an #AcademicCareer in #OncologyEducation” #Dialogue between 2 OUTSTANDING #Fellows in our program Mayo Clinic, Drs #Pai & Dina Elantably, MD, MS & me (a PROUD #ProgramDirector) 👇🏻 connection.asco.org/do/building-ac…

🔥🚨Hot off the press
JUST published <a href="/ASCO/">ASCO</a> #Connection 

An article on:
“Building an #AcademicCareer in #OncologyEducation” 

#Dialogue between 2 OUTSTANDING #Fellows in our program <a href="/MayoClinic/">Mayo Clinic</a>, Drs #Pai &amp; <a href="/DinaElantably/">Dina Elantably, MD, MS</a> &amp; me (a PROUD #ProgramDirector)

👇🏻
connection.asco.org/do/building-ac…